Portfolio Update

RNS Number : 5354A

Intl. Biotechnology Trust PLC

09 October 2009

 



INTERNATIONAL BIOTECHNOLOGY TRUST PLC    

Portfolio update as at 30 September 2009                    

Total Net Assets	£102.2m
NAV per share	157.7p
Share Price	132.0p
Total value of unquoted investments	£18.1m
Total number of portfolio companies	59
Cash	5%
Cash committed and reserved to unquoted investments	15%
Portfolio companies with < 1 year of cash	16%

Top Ten Holdings

Company Name	% NAV	Market Value
Micromet	9.49	9,701,224
Celgene	5.91	6,042,592
Amgen	5.37	5,488,218
Gilead Sciences	4.39	4,487,585
HSBC Sterling Liquid Fund B shares	3.42	3,500,489
Alexion Pharmaceuticals	3.22	3,295,028
Genzyme	3.17	3,243,787
Wright Medical	3.16	3,226,705
Affymax	3.05	3,120,966
EV3	2.67	2,727,712
	-----------	--------------
Total	43.85	44,834,306

Geographical Allocation	%
United States	78
Europe	15
Cash	5
Australia	2
	-----------
Total	100

Quoted/Unquoted allocation	%
Quoted	77
Unquoted	18
Cash	5
	-----------
	100

BNP Paribas Secretarial Services Limited

Company Secretary

9 OCTOBER 2009

 

END

 

 

PFUBGBDGGXGGGCC